Wearable Sensors and Molecular Omics to Detect and Mitigate Cell Therapy Adverse Events

Study Summary

The purpose of this study is to monitor physiological and molecular changes during and following CAR-T cancer cell therapy, towards improved management of adverse events including Cytokine Release Syndrome and neurotoxicity. Our study aims are to improved early detection and precise management of adverse events for patients receiving Chimeric antigen receptor T- cell (CAR-T): 1. To assess the feasibility, including accuracy, usability, and usefulness of wearable sensors in CAR-T patients. 2. To generate comprehensive multiomic profile analysis following CAR-T therapy. 3. To perform integrated analysis of wearables sensor data, omics data, and symptom/clinical data.

Interventions

No interventions listed.

Study Locations

Facility	City	State	Country
Stanford University	Palo Alto	California	United States

Official Trial Information

View on ClinicalTrials.gov